iRhythm Technologies (STU:I25) Tax Provision : €-0.6 Mil (TTM As of Sep. 2024)

View and export this data going back to 2017. Start your Free Trial

What is iRhythm Technologies Tax Provision?

iRhythm Technologies's tax provision for the three months ended in Sep. 2024 was €-0.2 Mil. Its tax provision for the trailing twelve months (TTM) ended in Sep. 2024 was €-0.6 Mil.

iRhythm Technologies Tax Provision Historical Data

The historical data trend for iRhythm Technologies's Tax Provision can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

iRhythm Technologies Tax Provision Chart

iRhythm Technologies Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Tax Provision

Get a 7-Day Free Trial

-0.06

-0.19

-0.33

-0.25

-0.69

iRhythm Technologies Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Tax Provision	Get a 7-Day Free Trial															-0.18	-0.23	-0.03	-0.18	-0.17

iRhythm Technologies Tax Provision Calculation

Tax to be paid.

Tax Provision for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.6 Mil.

iRhythm Technologies Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » iRhythm Technologies Inc (STU:I25) » Definitions » Tax Provision

Comparable Companies

Traded in Other Exchanges

IRTC:USA 0A7L:UK

Address

699 8th Street, Suite 600, San Francisco, CA, USA, 94103

Website

https://www.irhythmtech.com

iRhythm Technologies Inc is a commercial-stage digital healthcare company redefining the way cardiac arrhythmias are clinically diagnosed by combining wearable biosensing technology with cloud-based data analytics and machine-learning capabilities. The company's portfolio includes ambulatory cardiac monitoring services on a platform, called the Zio service, which combines an easy-to-wear and unobtrusive biosensor that can be worn for several days with powerful proprietary algorithms that distill data from millions of heartbeats into clinically actionable information. The company derived its revenue from the United States.

iRhythm Technologies Headlines

No Headlines